nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0377	0.0451	CcSEcCtD
Dorzolamide—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0366	0.0437	CcSEcCtD
Dorzolamide—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.0287	0.0343	CcSEcCtD
Dorzolamide—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.0281	0.0336	CcSEcCtD
Dorzolamide—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0278	0.0333	CcSEcCtD
Dorzolamide—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.018	0.0215	CcSEcCtD
Dorzolamide—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0209	CcSEcCtD
Dorzolamide—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0209	CcSEcCtD
Dorzolamide—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0198	CcSEcCtD
Dorzolamide—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0188	CcSEcCtD
Dorzolamide—CA1—nerve—amyotrophic lateral sclerosis	0.015	0.0914	CbGeAlD
Dorzolamide—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0169	CcSEcCtD
Dorzolamide—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0165	CcSEcCtD
Dorzolamide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0163	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0163	CcSEcCtD
Dorzolamide—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0157	CcSEcCtD
Dorzolamide—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0153	CcSEcCtD
Dorzolamide—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0152	CcSEcCtD
Dorzolamide—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0151	CcSEcCtD
Dorzolamide—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0146	CcSEcCtD
Dorzolamide—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0145	CcSEcCtD
Dorzolamide—CA4—nerve—amyotrophic lateral sclerosis	0.0117	0.0715	CbGeAlD
Dorzolamide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0133	CcSEcCtD
Dorzolamide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0129	CcSEcCtD
Dorzolamide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0127	CcSEcCtD
Dorzolamide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0124	CcSEcCtD
Dorzolamide—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0122	CcSEcCtD
Dorzolamide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.01	0.012	CcSEcCtD
Dorzolamide—Depression—Riluzole—amyotrophic lateral sclerosis	0.00986	0.0118	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00975	0.0117	CcSEcCtD
Dorzolamide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00969	0.0116	CcSEcCtD
Dorzolamide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00961	0.0115	CcSEcCtD
Dorzolamide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00948	0.0113	CcSEcCtD
Dorzolamide—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00932	0.0111	CcSEcCtD
Dorzolamide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00927	0.0111	CcSEcCtD
Dorzolamide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00923	0.011	CcSEcCtD
Dorzolamide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00903	0.0108	CcSEcCtD
Dorzolamide—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00883	0.0106	CcSEcCtD
Dorzolamide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00881	0.0105	CcSEcCtD
Dorzolamide—CA4—hindbrain—amyotrophic lateral sclerosis	0.00875	0.0535	CbGeAlD
Dorzolamide—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00839	0.01	CcSEcCtD
Dorzolamide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00793	0.00948	CcSEcCtD
Dorzolamide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00784	0.00938	CcSEcCtD
Dorzolamide—Tension—Riluzole—amyotrophic lateral sclerosis	0.00758	0.00906	CcSEcCtD
Dorzolamide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00757	0.00904	CcSEcCtD
Dorzolamide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0075	0.00897	CcSEcCtD
Dorzolamide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00747	0.00893	CcSEcCtD
Dorzolamide—CA2—hindbrain—amyotrophic lateral sclerosis	0.00726	0.0444	CbGeAlD
Dorzolamide—CA14—medulla oblongata—amyotrophic lateral sclerosis	0.00725	0.0443	CbGeAlD
Dorzolamide—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00706	0.00844	CcSEcCtD
Dorzolamide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00694	0.0083	CcSEcCtD
Dorzolamide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00693	0.00828	CcSEcCtD
Dorzolamide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00683	0.00816	CcSEcCtD
Dorzolamide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00679	0.00812	CcSEcCtD
Dorzolamide—Cough—Riluzole—amyotrophic lateral sclerosis	0.00674	0.00806	CcSEcCtD
Dorzolamide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00667	0.00797	CcSEcCtD
Dorzolamide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00658	0.00786	CcSEcCtD
Dorzolamide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00658	0.00786	CcSEcCtD
Dorzolamide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00655	0.00784	CcSEcCtD
Dorzolamide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0065	0.00777	CcSEcCtD
Dorzolamide—CA14—spinal cord—amyotrophic lateral sclerosis	0.00646	0.0395	CbGeAlD
Dorzolamide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00643	0.00769	CcSEcCtD
Dorzolamide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00636	0.0076	CcSEcCtD
Dorzolamide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0063	0.00754	CcSEcCtD
Dorzolamide—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0063	0.00754	CcSEcCtD
Dorzolamide—Shock—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00742	CcSEcCtD
Dorzolamide—CA7—cerebellum—amyotrophic lateral sclerosis	0.00615	0.0376	CbGeAlD
Dorzolamide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0061	0.00729	CcSEcCtD
Dorzolamide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00601	0.00719	CcSEcCtD
Dorzolamide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00704	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00574	0.00687	CcSEcCtD
Dorzolamide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0057	0.00682	CcSEcCtD
Dorzolamide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00566	0.00677	CcSEcCtD
Dorzolamide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00672	CcSEcCtD
Dorzolamide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00561	0.0067	CcSEcCtD
Dorzolamide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00555	0.00664	CcSEcCtD
Dorzolamide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00655	CcSEcCtD
Dorzolamide—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00544	0.0065	CcSEcCtD
Dorzolamide—CA9—cerebellum—amyotrophic lateral sclerosis	0.0054	0.033	CbGeAlD
Dorzolamide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00645	CcSEcCtD
Dorzolamide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00621	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00516	0.00616	CcSEcCtD
Dorzolamide—CA14—cerebellum—amyotrophic lateral sclerosis	0.00512	0.0313	CbGeAlD
Dorzolamide—CA4—brainstem—amyotrophic lateral sclerosis	0.00502	0.0307	CbGeAlD
Dorzolamide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00599	CcSEcCtD
Dorzolamide—CA7—brain—amyotrophic lateral sclerosis	0.005	0.0305	CbGeAlD
Dorzolamide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00596	CcSEcCtD
Dorzolamide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00498	0.00596	CcSEcCtD
Dorzolamide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00465	0.00555	CcSEcCtD
Dorzolamide—CA2—embryo—amyotrophic lateral sclerosis	0.00454	0.0278	CbGeAlD
Dorzolamide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00452	0.00541	CcSEcCtD
Dorzolamide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00533	CcSEcCtD
Dorzolamide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00516	CcSEcCtD
Dorzolamide—CA12—nervous system—amyotrophic lateral sclerosis	0.00425	0.026	CbGeAlD
Dorzolamide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00417	0.00498	CcSEcCtD
Dorzolamide—CA14—brain—amyotrophic lateral sclerosis	0.00416	0.0254	CbGeAlD
Dorzolamide—CA2—brainstem—amyotrophic lateral sclerosis	0.00416	0.0254	CbGeAlD
Dorzolamide—CA12—central nervous system—amyotrophic lateral sclerosis	0.00409	0.025	CbGeAlD
Dorzolamide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00479	CcSEcCtD
Dorzolamide—CA1—spinal cord—amyotrophic lateral sclerosis	0.00399	0.0244	CbGeAlD
Dorzolamide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00475	CcSEcCtD
Dorzolamide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00475	CcSEcCtD
Dorzolamide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00472	CcSEcCtD
Dorzolamide—CA5B—nervous system—amyotrophic lateral sclerosis	0.00381	0.0233	CbGeAlD
Dorzolamide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00448	CcSEcCtD
Dorzolamide—CA5B—central nervous system—amyotrophic lateral sclerosis	0.00367	0.0224	CbGeAlD
Dorzolamide—CA4—medulla oblongata—amyotrophic lateral sclerosis	0.0035	0.0214	CbGeAlD
Dorzolamide—CA1—nervous system—amyotrophic lateral sclerosis	0.00336	0.0206	CbGeAlD
Dorzolamide—CA12—brain—amyotrophic lateral sclerosis	0.00325	0.0198	CbGeAlD
Dorzolamide—CA1—central nervous system—amyotrophic lateral sclerosis	0.00324	0.0198	CbGeAlD
Dorzolamide—CA4—spinal cord—amyotrophic lateral sclerosis	0.00312	0.0191	CbGeAlD
Dorzolamide—CA5B—brain—amyotrophic lateral sclerosis	0.00291	0.0178	CbGeAlD
Dorzolamide—CA2—medulla oblongata—amyotrophic lateral sclerosis	0.0029	0.0177	CbGeAlD
Dorzolamide—CA4—nervous system—amyotrophic lateral sclerosis	0.00263	0.0161	CbGeAlD
Dorzolamide—CA2—spinal cord—amyotrophic lateral sclerosis	0.00259	0.0158	CbGeAlD
Dorzolamide—CA1—brain—amyotrophic lateral sclerosis	0.00257	0.0157	CbGeAlD
Dorzolamide—CA4—central nervous system—amyotrophic lateral sclerosis	0.00253	0.0155	CbGeAlD
Dorzolamide—CA4—cerebellum—amyotrophic lateral sclerosis	0.00247	0.0151	CbGeAlD
Dorzolamide—CA2—nervous system—amyotrophic lateral sclerosis	0.00218	0.0133	CbGeAlD
Dorzolamide—CA2—central nervous system—amyotrophic lateral sclerosis	0.0021	0.0128	CbGeAlD
Dorzolamide—CA2—cerebellum—amyotrophic lateral sclerosis	0.00205	0.0125	CbGeAlD
Dorzolamide—CA4—brain—amyotrophic lateral sclerosis	0.00201	0.0123	CbGeAlD
Dorzolamide—CA2—brain—amyotrophic lateral sclerosis	0.00167	0.0102	CbGeAlD
Dorzolamide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00141	0.0086	CbGeAlD
Dorzolamide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00135	0.00828	CbGeAlD
